Lotte Knudsen, who pushed Novo Nordisk into the Ozempic era, wins STAT Innovation Prize
BIn the 1990s, scientist Lotte Bjerre Knudsen was tasked with revitalizing a struggling program at Novo Nordisk that was attempting to harness the newly discovered hormone GLP-1 into viable drug candidates for diabetes. At the time, many Knudsens executives had already lost hope in this program. After all, Novos focused on insulin, and the natural …